<i>In Vitro</i> Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli

Shawn Vasoo, Scott A. Cunningham, Nicolynn C. Cole, Peggy C. Kohner, Sanjay Menon, Kevin M. Krause, Kelly Harris, Partha Pratim De, Tse Hsien Koh, Robin Patel

Antimicrobial Agents and Chemotherapy · 2015 · 83 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Among 177 carbapenemase-producing Gram-negative bacilli (108 KPC, 32 NDM, 11 IMP, 8 OXA-48, 4 OXA-181, 2 OXA-232, 5 IMI, 4 VIM, and 3 SME producers), aztreonam-avibactam was active against all isolates except two NDM producers with elevated MICs of 8/4 and 16/4 mg/liter; ceftazidime-avibactam was active against all KPC-, IMI-, SME-, and most OXA-48 group-producing isolates (93%) but not metallo-β-lactamase producers. Among older and contemporary antimicrobials, the most active were colistin, tigecycline, and fosfomycin, with overall susceptibilities of 88%, 79%, and 78%, respectively.

References

18